Five years on, biosimilars need support from all health care players
Oncology Practice Management
Best Practices for Integrating Biosimilars into Your Oncology Practice
Biosimilars – Let’s Not Throw the Baby Out with the Bathwater
5 Years of Biosimilars in the US: What Have We Learned?
Biosimilar Education Series
Discover how the emergence of biosimilars impacts oncology practices, manufacturers and the industry in our education series.
Biosimilar by Partner
Become an ION Solutions member
Our GPO members get a lot more than just contracted drug pricing. Contact our team to learn how our solutions can help your practice operate more efficiently, close reporting gaps, and advance the quality of patient care.